Peritoneal Dialysis International, July 2021
Authors: Graham Abra, Eric D Weinhandl
Background:
Both peritoneal dialysis (PD) and home hemodialysis (HHD) offer well-documented advantages and are typically associated with lower total costs in high-income countries. In the United States, the last decade has seen growth in these modalities, at least partially driven by payment changes, and continuing during the COVID-19 global pandemic. Despite this growth, prevalent utilisation of home dialysis in the US still lags utilisation in other high-income countries, including Australia (25%), Canada (25%), New Zealand (44%) and the United Kingdom (17%).